Family history is at the core of precision medicine, Joy Larsen Haidle, MS, CGC, 2015 president of the National Society of Genetic Counselors, said during her presentation at The American Journal of Managed Care’s 4th Annual Patient-Centered Oncology Care Meeting. During her presentation, Haidle explained that while hereditary cancer was traditionally viewed as occurring between 5% and 10% of the cancer population, recent data suggest that number may be a lot closer to 25% today.
Family history is at the core of precision medicine, Joy Larsen Haidle, MS, CGC, 2015 president of the National Society of Genetic Counselors, said during her presentation at The American Journal of Managed Care’s 4th Annual Patient-Centered Oncology Care Meeting. During her presentation, Haidle explained that while hereditary cancer was traditionally viewed as occurring between 5% and 10% of the cancer population, recent data suggest that number may be a lot closer to 25% today.
Haidle explained that identifying patients earlier could lead to heightened surveillance, risk-reducing surgeries, and behavior modifications, allowing family members to know earlier if they may be at risk. As important as early detection may be, family history isn’t always at the top of the to-do list for practitioners who may be tasked with a handful items in a short appointment time. As a result, family history is generally either not collected at all or is done so very minimally.
“The world of genetic testing is under a rapid, rapid change, especially in the last 18 months to 2 years. And it’s important that the clinical expertise keep pace with the technology,” Haidle explained. “There are 10 new tests that are hitting the market on a daily basis. That’s a lot for the average practitioner to try to keep on top of and to sort through. In addition to the increased volume, the kind of information, the complexity of that information, has dramatically changed as well.”
Access to genetic testing has increased with the help of this technology. Though traditional face-to-face interactions still exist, telephone and telegenetic services have allowed greater access to rural and underserved areas. And with the addition of genetic counseling as part of the testing services, Haidle added that studies have shown the combination to decrease costs. Genetic counseling has not only decreased costs by reducing the number of inappropriate tests, but genetic counselors have also helped by identifying risk factors that may have been missed by the family practitioner.
“I also want to highlight the value of the counseling skills that come to that interaction because that support, and being able to understand how to use that information, the medical care becomes extremely important,” Haidle said.
Rare Autoimmune Disorder Linked With Increased Risk of Certain Skin Cancers
April 21st 2025The risk of some skin cancers, including squamous cell carcinoma, basal cell carcinoma, and non-melanoma skin cancer, was particularly heightened among patients with severe mucous membrane pemphigoid.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage
April 4th 2025This study examined postdiagnosis breast cancer treatment outcomes for Medicare Advantage vs fee-for-service (FFS) Medicare in Ohio and found no significant differences overall but disparities for Black patients with FFS Medicare.
Read More